Merz, M., Salwender, H., Haenel, M., Mai, E. K., Bertsch, U., Kunz, C., . . . Goldschmidt, H. (2015). Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: An interim analysis from the prospective GMMG-MM5 trial. Haematologica.
Chicago ZitierstilMerz, Maximilian, et al. "Subcutaneous Versus Intravenous Bortezomib in Two Different Induction Therapies for Newly Diagnosed Multiple Myeloma: An Interim Analysis From the Prospective GMMG-MM5 Trial." Haematologica 2015.
MLA ZitierstilMerz, Maximilian, et al. "Subcutaneous Versus Intravenous Bortezomib in Two Different Induction Therapies for Newly Diagnosed Multiple Myeloma: An Interim Analysis From the Prospective GMMG-MM5 Trial." Haematologica 2015.